Gershonov E, Granoth R, Tzehoval E, Gaoni Y, Fridkin M
Department of Organic Chemistry, Weizmann Institute of Science, Rehovot, Israel.
J Med Chem. 1996 Nov 22;39(24):4833-43. doi: 10.1021/jm960390t.
Four novel 2,4-methano amino acids (MAAs, 1-aminocyclobutane-1-carboxylic acids) were synthesized. These include the basic MAA analogs of lysine (16), ornithine (5), and arginine (6) and the neutral methanovaline (22), related to proline. The above MAAs, as well as the MAA analog of homothreonine (7), were incorporated into the peptide chain of the immunomodulatory peptide tuftsin, Thr-Lys-Pro-Arg, known to enhance several biological activities mediated by phagocytic cells. The synthetic methano tuftsin analogs were assayed for their ability to stimulate interleukin-6 (IL-6) secretion by mouse peritoneal macrophages and for their stability in human serum toward enzymatic degradation. It was found that, at 2 x 10(-7) M, [MThr1]tuftsin (24) and an isomer of [MVal3]tuftsin (27a) were considerably more active than the parent peptide in augmentation of cytokine release. [MOrn2]Tuftsin (25) was equally potent. The analogs [MThr1]tuftsin (24) and [MOrn2]tuftsin (25), both pertaining to the proteolytically sensitive Thr-Lys bond of tuftsin, exhibited high resistance to enzymatic hydrolysis as compared to tuftsin. Using specific rabbit anti-tuftsin antibodies in a competitive enzyme-linked immunosorbent assay (ELISA) revealed that none of the MAA analogs can cross-react with tuftsin. It may indicate that the peptides assume global structures different than that of tuftsin.
合成了四种新型的2,4-亚甲基氨基酸(MAA,1-氨基环丁烷-1-羧酸)。这些包括赖氨酸(16)、鸟氨酸(5)和精氨酸(6)的碱性MAA类似物以及与脯氨酸相关的中性甲硫氨酸(22)。上述MAA以及高苏氨酸的MAA类似物(7)被掺入免疫调节肽促吞噬素(Thr-Lys-Pro-Arg)的肽链中,已知该肽可增强吞噬细胞介导的多种生物活性。对合成的亚甲基促吞噬素类似物进行了检测,以评估它们刺激小鼠腹腔巨噬细胞分泌白细胞介素-6(IL-6)的能力以及它们在人血清中对酶促降解的稳定性。结果发现,在2×10⁻⁷ M时,[MThr1]促吞噬素(24)和[MVal3]促吞噬素的一种异构体(27a)在增加细胞因子释放方面比母体肽的活性要高得多。[MOrn2]促吞噬素(25)具有同等效力。与促吞噬素相比,[MThr1]促吞噬素(24)和[MOrn2]促吞噬素(25)这两种与促吞噬素对蛋白酶敏感的Thr-Lys键相关的类似物对酶促水解表现出高度抗性。在竞争性酶联免疫吸附测定(ELISA)中使用特异性兔抗促吞噬素抗体表明,没有一种MAA类似物能与促吞噬素发生交叉反应。这可能表明这些肽呈现出与促吞噬素不同的整体结构。